HYRIMOZ sol inj 40 mg/0.4ml ser pré 2 x 0.4 ml

7680672580081 CH-67258 L04AB04 07.15.0.

Reimbursement limitations:

HYRIMOZ20mg2

Le dosage de 20 mg d'HYRIMOZ est exclusivement réservé aux enfants et aux adolescents.

…

HYRIMOZ sol inj 40 mg/0.4ml ser pré 2 x 0.4 ml
HYRIMOZ sol inj 40 mg/0.4ml ser pré 2 x 0.4 ml
1 / 2
google

Details

Product number
6725804
CPT
-
Packaging group
2
Unit
Fertigspritze(n)
Composition
adalimumabum 40 mg, acidum adipicum, mannitolum, polysorbatum 80, natrii hydroxidum aut acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 0.4 ml corresp. natrium 0.12 mg.

Articles (1)

Hyrimoz 40 mg/0.4 ml, Injektionslösung in Fertigspritzen
Injektionslösung
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/07/2025
Patient information leaflet
Français
03/07/2025
Patient information leaflet
Italien
03/07/2025
Professional SmPC
Allemand
03/07/2025
Professional SmPC
Français
03/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.12 MG Substance HBESI

Reimbursement information

Public price
CHF 815.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2025

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
67258
Drug name
Hyrimoz, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AB04
Authorization status
Z
Dispensation category
B
First authorization
13/09/2019
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, Polyartikuläre juvenile idiopathische Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis (Morbus Bechterew), Morbus Crohn bei Erwachsenen sowie Kindern und Jugendlichen, Colitis ulcerosa, Psoriasis bei Erwachsenen und Jugendlichen ab 47 kg Körpergewicht, Hidradenitis suppurativa (Acne inversa), Uveitis

Packaging details

Description (FR)
HYRIMOZ sol inj 40 mg/0.4ml ser pré 2 x 0.4 ml
Description (DE)
HYRIMOZ Inj Lös 40 mg/0.4ml Fertspr 2 x 0.4 ml
Market launch
28/05/2024
Narcotic (BTM)
No

Other packaging sizes

HYRIMOZ sol inj 40 mg/0.8ml ser pré 0.8 ml
1 FESP
GTIN: 7680672580012
View
HYRIMOZ sol inj 40 mg/0.8ml 2 ser pré 0.8 ml
2 FESP
GTIN: 7680672580029
View
HYRIMOZ sol inj 40 mg/0.8ml 6 ser pré 0.8 ml
6 FESP
GTIN: 7680672580036
View
HYRIMOZ sol inj 20 mg/0.4ml 2 ser pré 0.4 ml
2 FESP
GTIN: 7680672580043
View
HYRIMOZ sol inj 80 mg/0.8ml ser pré 0.8 ml
1 FESP
GTIN: 7680672580050
View
HYRIMOZ sol inj 40 mg/0.4ml ser pré 0.4 ml
1 FESP
GTIN: 7680672580074
View
HYRIMOZ sol inj 40 mg/0.4ml ser pré 6 x 0.4 ml
6 FESP
GTIN: 7680672580098
View
HYRIMOZ sol inj 20 mg/0.2ml ser pré 2 x 0.2 ml
2 FESP
GTIN: 7680672580104
View